Prolapse of Rectum OR Gudabhransa and its Ayurvedic treatment
Not Applicable
- Conditions
- Health Condition 1: K623- Rectal prolapse
- Registration Number
- CTRI/2021/03/032042
- Lead Sponsor
- DrNagesh Kumar Yadav
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Partial prolapse of rectum
Mucosal Prolapse
patients not willing for major surgery
Exclusion Criteria
Prolapse haemorrhoids
Carcinoma of rectum
Complete rectal prolapse
Cystocoel
Rectocoel
Colitis
Uncontrolled diabetic mellitus
Immuno-compromised patients
Sentinel Tag
Haemorrhoid
HIV/HBsAg positive subjects
Patient with any systemic infection
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Wexner Incontinence scoreTimepoint: 3 months
- Secondary Outcome Measures
Name Time Method ANAL TONE BY anal manometryTimepoint: 1 month;ANAL TONE BY PER RECTAL DIGITAL EXAMINATIONTimepoint: 1 month
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie rectal prolapse (K623) and potential Ayurvedic therapeutic targets?
How does Ayurvedic treatment for Gudabhransa compare to standard-of-care surgical interventions in clinical outcomes?
Are there specific biomarkers that can predict patient response to Ayurvedic interventions for rectal prolapse?
What are the known adverse events associated with Ayurvedic treatments for rectal prolapse and how are they managed?
What combination approaches or competitor drugs exist for managing rectal prolapse beyond Ayurvedic therapies?